Iaso Therapeutics, Inc. — Form D
Iaso Therapeutics, Inc. of EAST LANSING, MI, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-14. The offering totals $1.8M, of which $570K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-01-14
- Form: D
- Accession: 0000905729-26-000020
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.8M
- Amount sold: $570K
- Remaining: $1.2M
- Minimum investment: $25K
- Investors: 1
- Date of first sale: 2026-01-09
- Revenue range: Decline to Disclose
- SEC file number: 021-569984
Issuer
- Name: Iaso Therapeutics, Inc.
- CIK: 0001961165
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 4942 DAWN AVE, EAST LANSING, MI, 48823
- Phone: 773-437-0274
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Steve Kuemmerie | Director | East Lansing, MI |
| Xuefei Huang | Director | East Lansing, MI |
| Xuefei Huang | Executive Officer | East Lansing, MI |
| Herbert Kavunja | Executive Officer | East Lansing, MI |
| Jeffrey Wesley | Director | East Lansing, MI |
| Donald Parfet | Director | Kalamazoo, MI |
| Robert Forgey | Director | EAST LANSING, MI |
| Robert Forgey | Executive Officer | EAST LANSING, MI |
Other filings by this issuer (1)
More